NCT06612346Completed
Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study
Source: ClinicalTrials.gov · Last updated 10 Jan 2025
Brief summary (registry, in English)
This study is a follow-up extension study conducted in continuation of the prior MINT study (MMS-EEU-4), in which the long-term (i.e., 18, 24 months) clinical outcomes of Minimally Invasive Nasal Trabeculostomy (MINT) will be explored.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 36 (actual)
- First submitted
- 27 Aug 2024
- Start date
- 4 Nov 2022
- Primary completion date
- 22 Oct 2024
- Lead sponsor
- Sanoculis Ltd
- Diseases
- Glaucoma
- NCT number
- NCT06612346
What you commit to
- Study type: Observational
- Participants enrolled: 36
- From 4 Nov 2022 to the primary completion date, 22 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Male or female ≥ 18 years to ≤ 85 years old
- Subject who underwent MINT, and surgery was performed not earlier than 18 months from enrollment
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| S. Malayan Eye Center Coordinator of this site? Confirm its status | Yerevan | Armenia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.